These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7371683)

  • 21. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
    [No Abstract]   [Full Text] [Related]  

  • 22. Appearance and distribution of virally determined antigens in lymphoid organs of mice during leukemogenesis by Moloney leukemia virus.
    Asjö B; Fenyö EM; Spira J; Klein G
    Leuk Res; 1980; 4(1):89-103. PubMed ID: 7412358
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
    Lamon EW; Skurzak HM; Klein E; Wigzell H
    J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188
    [No Abstract]   [Full Text] [Related]  

  • 24. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
    Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
    [No Abstract]   [Full Text] [Related]  

  • 25. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitory effects of xenogeneic antiserum on the growth of Moloney virus-induced sarcomas.
    Pierce GE
    J Surg Oncol; 1977; 9(3):249-56. PubMed ID: 875394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenic properties of a nonproducer malignant tumor induced by murine sarcoma virus.
    Law LW; Chang KS; Ting RC
    Proc Soc Exp Biol Med; 1976 Sep; 152(4):585-8. PubMed ID: 967890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on Murine Sarcoma Virus: antigenic characterization of Murine Sarcoma Virus induced tumor cells.
    Chuat JC; Berman L; Gunvén P; Klein E
    Int J Cancer; 1969 Jul; 4(4):465-79. PubMed ID: 4899685
    [No Abstract]   [Full Text] [Related]  

  • 29. Moloney virus (M-MuLV) leukemogenesis: virus spread, antibody production and antigenic expression in neonatally virus-inoculated young mice.
    Asjö B; Fenyö EM; Klein G
    Int J Cancer; 1981 Jul; 28(1):65-70. PubMed ID: 7309282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
    Cloyd MW; Evans LH
    J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections.
    Schlom J; Moloney JB; Groupé V
    Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580
    [No Abstract]   [Full Text] [Related]  

  • 32. A non-virion surface antigen on Moloney sarcoma virus-transformed non-producer and producer cells.
    Hunsmann G; Weiland E; Mussgay M; Schneider J
    J Gen Virol; 1980 Aug; 49(2):375-84. PubMed ID: 6255072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene.
    Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ; Turner HC
    J Natl Cancer Inst; 1971 Dec; 47(6):1255-65. PubMed ID: 4330465
    [No Abstract]   [Full Text] [Related]  

  • 34. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
    Pazmiño NH; Yuhas JM
    Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
    [No Abstract]   [Full Text] [Related]  

  • 36. Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.
    Aoki T; Stephenson JR; Aaronson SA
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):742-6. PubMed ID: 4351802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic control of sensitivity to moloney leukemia virus in mice. VI. Involvement of virus-specific T helper cells collaborating with B cells.
    Boyer B; Debré P; Seman M; Zilberfarb V; Lévy JP
    Eur J Immunol; 1982 Aug; 12(8):692-7. PubMed ID: 6216112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW; Skurzak HM; Klein E
    Int J Cancer; 1972 Nov; 10(3):581-8. PubMed ID: 4128689
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.